Preface List of Contributors 1 Cancer Biotherapy: Progress in China 2 Cancer Targeting Gene-Viro-Therapy and Its Promising Future 3 Relationship Between Antiproliferative Activities and Class I MHC Surface Expression of Mouse Interferon Proteins on B16-Fl0 Melanoma Cells 4 Mitotic Regulator Hecl as a Potential Target for Cancer Therapy 5 Advances in Liposome-Based Targeted Gene Therapy of Cancer 6 Rewiring the Intracellular Signaling Network in Cancer 7 Research and Development of Highly Potent Antibody-Based Drug Conjugates and Fusion Proteins for Cancer Therapy 8 Cancer Stem Cell 9 p53: A Target and a Biomarker of Cancer Therapy? 10 Recombinant Adenoviral-p53 Agent （Gendicine）: Quality Control, Mecharusm of Action, and Its Use for Treatment of Malignant Tumors 11 Three-Dimensional Tumor Model and T-Lymphocytes Immunotherapy for Cancer 12 Advances in Cancer Chemotherapeutic Drug Research in China 13 Doxorubicin Cardiotoxicity Revisited: ROS Versus Top2 14 Biochemistry and Pharmacology of Human ABCC1/MRP1 and Its Role in Detoxification and in Multidrug Resistance of Cancer Chemotherapy 15 The Role of Traditional Chinese Medicine in Clinical Oncology 16 Effect of Arsenic Trioxide on Acute Promyelocytic Leukemia and Glioma: Experimental Studies, Clinical Applications, and Perspectives 17 Recent Advances in Nasopharyngeal Carcinoma Research and Its Pathogenesis 18 EsophageaI Carcinoma 19 Research on Colorectal Cancer in China 20 Molecular and Cellular Characteristics of Small CeH Lung Cancer: Implications for Molecular-Targeted Cancer Therapy 21 Possibility to Partly Win the War Against Cancer About the Editors
鄂公網(wǎng)安備 42010302001612號(hào) 